LGND · Ligand Pharmaceuticals Inc · Exempt Offerings
$322.75
+5.42 (+1.71%)
At close · Oct 30
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$6.43B
Shares
20.00M
Volume · Oct 30
344.37K
Avg daily vol (3M)
241.18K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
886163
CUSIP
53220K504
13F (30d)
134 filings
125 filers
Visit website
Investor relations